Karin G Johnson1,2, Shannon S Sullivan3, Afua Nti4, Vida Rastegar5, Indira Gurubhagavatula6,7. 1. Department of Neurology, Baystate Medical Center, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts. 2. Institute for Healthcare Delivery and Population Science and Department of Medicine, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts. 3. Department of Pediatrics, Division of Pulmonary, Asthma & Sleep Medicine, Stanford University School of Medicine, Palo Alto, California. 4. University of Massachusetts Medical School-Baystate, Springfield, Massachusetts. 5. Department of Medicine, Baystate Medical Center, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts. 6. Division of Sleep Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. 7. Crescenz VA Medical Center, Philadelphia, Pennsylvania.
Abstract
STUDY OBJECTIVES: The COVID-19 pandemic required sleep centers to consider and implement infection control strategies to mitigate viral transmission to patients and staff. Our aim was to assess measures taken by sleep centers due to the COVID-19 pandemic and plans surrounding reinstatement of sleep services. METHODS: We distributed an anonymous online survey to health care providers in sleep medicine on April 29, 2020. From responders, we identified a subset of unique centers by region and demographic variables. RESULTS: We obtained 379 individual responses, which represented 297 unique centers. A total of 93.6% of unique centers reported stopping all or nearly all sleep testing of at least one type, without significant differences between adult and pediatric labs, geographic region, or surrounding population density. By contrast, a greater proportion of respondents continued home sleep apnea testing services. A total of 60.3% reduced home sleep apnea testing volume by at least 90%, compared to 90.4% that reduced in-laboratory testing by at least 90%. Respondents acknowledged that they implemented a wide variety of mitigation strategies. While no respondents reported virtual visits to be ≥ 25% of clinical visits prior to the pandemic, more than half (51.9%) anticipated maintaining ≥ 25% virtual visits after the pandemic. CONCLUSIONS: Among surveyed sleep centers, the vast majority reported near-cessation of in-laboratory sleep studies, while a smaller proportion reported reductions in home sleep apnea tests. A large increase in the use of telemedicine was reported, with the majority of respondents expecting the use of telehealth to endure in the future.
STUDY OBJECTIVES: The COVID-19 pandemic required sleep centers to consider and implement infection control strategies to mitigate viral transmission to patients and staff. Our aim was to assess measures taken by sleep centers due to the COVID-19 pandemic and plans surrounding reinstatement of sleep services. METHODS: We distributed an anonymous online survey to health care providers in sleep medicine on April 29, 2020. From responders, we identified a subset of unique centers by region and demographic variables. RESULTS: We obtained 379 individual responses, which represented 297 unique centers. A total of 93.6% of unique centers reported stopping all or nearly all sleep testing of at least one type, without significant differences between adult and pediatric labs, geographic region, or surrounding population density. By contrast, a greater proportion of respondents continued home sleep apnea testing services. A total of 60.3% reduced home sleep apnea testing volume by at least 90%, compared to 90.4% that reduced in-laboratory testing by at least 90%. Respondents acknowledged that they implemented a wide variety of mitigation strategies. While no respondents reported virtual visits to be ≥ 25% of clinical visits prior to the pandemic, more than half (51.9%) anticipated maintaining ≥ 25% virtual visits after the pandemic. CONCLUSIONS: Among surveyed sleep centers, the vast majority reported near-cessation of in-laboratory sleep studies, while a smaller proportion reported reductions in home sleep apnea tests. A large increase in the use of telemedicine was reported, with the majority of respondents expecting the use of telehealth to endure in the future.
Authors: A K Simonds; A Hanak; M Chatwin; Mj Morrell; A Hall; K H Parker; J H Siggers; R J Dickinson Journal: Health Technol Assess Date: 2010-10 Impact factor: 4.014
Authors: Joseph Barker; Oluwatobiloba Oyefeso; David Koeckerling; Nadeesha Lakmal Mudalige; Daniel Pan Journal: Thorax Date: 2020-04-09 Impact factor: 9.139
Authors: Nurit Fox; A J Hirsch-Allen; Elizabeth Goodfellow; Joshua Wenner; John Fleetham; C Frank Ryan; Mila Kwiatkowska; Najib T Ayas Journal: Sleep Date: 2012-04-01 Impact factor: 5.849
Authors: Jaspal Singh; M Safwan Badr; Wendy Diebert; Lawrence Epstein; Dennis Hwang; Valerie Karres; Seema Khosla; K Nicole Mims; Affifa Shamim-Uzzaman; Douglas Kirsch; Jonathan L Heald; Kathleen McCann Journal: J Clin Sleep Med Date: 2015-10-15 Impact factor: 4.062
Authors: Seema Khosla; Elena Beam; Michael Berneking; Joseph Cheung; Lawrence J Epstein; Brittany J Meyer; Kannan Ramar; Jennifer Y So; Shannon S Sullivan; Lisa F Wolfe; Indira Gurubhagavatula Journal: J Clin Sleep Med Date: 2022-08-01 Impact factor: 4.324
Authors: Eileen Chaves; Sheethal D Reddy; Adelle Cadieux; Jessica Tomasula; Kimberly Reynolds Journal: Int J Environ Res Public Health Date: 2022-05-05 Impact factor: 4.614
Authors: Lucas M Donovan; Ashley C Mog; Kelly N Blanchard; Kate H Magid; Adnan S Syed; Lynette R Kelley; Brian N Palen; Elizabeth C Parsons; Catherine C McCall; William Thompson; Matthew Charlton; Laura J Spece; Susan Kirsh; David H Au; George G Sayre Journal: J Clin Sleep Med Date: 2021-08-01 Impact factor: 4.324
Authors: B L Radhakrishnan; E Kirubakaran; Immanuel Johnraja Jebadurai; A Immanuel Selvakumar; J Dinesh Peter Journal: Front Public Health Date: 2022-04-12